Topic
Confluences are ORTEX's highest-conviction signal class. A Confluence fires when three or more independent data types — short interest, cost to borrow, options flow, analyst downgrades, institutional flows — simultaneously cross thresholds on a single ticker. These are rare and loud.
Truist Securities upgraded EXR to Buy this morning, even as it cut its price target to $147. The stock sits at $133, down 5.7% over the past month. That gap between where the stock trades and where analysts think it…
Why this matters: Three weeks before Northrop Grumman reports on October 20, a rare alignment has formed: a high-profile analyst downgrade, a doubling of the cost to borrow shares, and a spike in retail attention. Each…
Short sellers have quietly exited NU over the past two weeks. Retail traders have piled in at precisely the wrong moment. The gap between those two movements is the story. Short interest in Nu Holdings fell 19.8% over…
Ford has shed 12% in a month and now trades at $12.27, more than 23% below the average analyst price target of $16.03. Short positions have continued to build. The Q3 earnings date is 24 days away. Short interest…
A convergence report published earlier today covered the Piper Sandler downgrade and the initial short interest build on EQBK. Since then, the cost to borrow has broken sharply higher. That move deserves its own…
Options traders have built the most heavily put-skewed position in Piper Sandler's 52-week history. Short sellers are adding exposure at the same time. The stock is down 7.5% over the past week. The put-call ratio on…
The retreat by short sellers in Solstice Advanced Materials has continued since Tuesday's note, and options positioning has grown even more one-sided. Two days on, both signals are more pronounced. Short interest now…
William Blair's downgrade arrived just before AYI reported. The stock fell 3.4% over the past week. Now short interest is climbing back, and the cost to borrow has followed. Why this matters: Three signals are moving…
Why this matters: Three distinct data streams are moving simultaneously on ABBV. Retail attention has jumped to nearly three standard deviations above its 90-day norm. Short sellers have been cutting positions for…
Why this matters: JPMorgan Chase has spent two weeks shedding short positions. Now, 11 days before Q3 earnings, the cost to borrow its shares has spiked 144% in a week. Short interest is at a six-month low. The borrow…
Three distinct signals converged on EQBK this week. Piper Sandler downgraded the stock. Short interest jumped sharply. Put buying hit its highest level since August. With earnings eleven days away and the Lincoln…
Rothschild & Co upgraded Abbott Laboratories to Buy this morning, lifting its target to $127 from $119. The stock trades at $96.69, implying 31% upside to the new target. The timing matters: earnings are due October…
Three signals converged on ABUS overnight. The borrow market has tightened dramatically, short interest has surged, and options traders are leaning bullish. The ORTEX short score hit 90.2, up from 58.6 two weeks…
First Horizon Corporation has attracted competing pre-earnings bets. Shorts have rebuilt positions, options traders have swung call-heavy, and two analysts have trimmed targets in 48 hours. The sharpest development of…
Short sellers added heavily to positions in NSC over the past week. The increase is sharp and worth watching. The lending market, however, tells a different story. Estimated short interest in Norfolk Southern rose 34%…
BMO Capital cut SGML to Market Perform on Thursday, setting a $10 target against a stock already down 23% in September. Short interest rose 30% in a week to 3.3% of free float. The two signals are pointing in the same…
Two conflicting signals have emerged on SMFG this week. Short sellers are retreating. Yet the cost to borrow those same shares has quadrupled overnight, and the options market just hit its most bearish reading in a…
Why this matters: The borrow cost on Warner Bros. Discovery jumped 90% in a week, even as short sellers continue to exit. Three distinct signals now converge into October, and none of them point the same way. The cost…
Nektar Therapeutics has clawed back 5% over the past week to $60.55. Short sellers have been cutting positions. But the options market tells a different story. Why this matters: Three distinct signals are now pointing…
Goldman Sachs lifted OXY to Buy on Thursday, setting a $69 price target. The move stands out because it arrives while short sellers have been adding exposure and the stock has slipped 6.4% over the past month. Neil…
On ORTEX you can subscribe to Confluence alerts per ticker or watchlist. The same signal engine that produces these reports powers the live alerts inside the platform.
Every ticker in the ORTEX universe is scored across six independent signal dimensions: short interest, cost to borrow, utilization, options flow, analyst consensus shifts, and institutional positioning changes. Each dimension carries its own threshold.
When three or more dimensions cross their thresholds in the same direction within a short window, a Confluence is triggered. The report summarises which signals fired, the magnitude of each, and the ORTEX interpretation.
Every contributing signal is recorded with timestamps in the report's provenance panel so readers can audit the trigger end to end.
